androgenetic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention group: First, the extracellular vesicles isolated from Wharton's jelly umbilical cord mesenchymal stem cells are separated and stored in phosphate buffered saline (PBS) in the freezer. It
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with male hereditary-hormonal hair loss Patients with hair loss grade three to four Norwood-Hamilton classification
Exclusion criteria
Exclusion criteria: Patients receiving treatment for androgenetic alopecia during the last 3 months Patients receiving systematic treatment of immunosuppressive or modulating drugs in the last 3 months Patients receiving anticoagulants Patients with a history of hair transplantation Patients with a history of malignancy Patients with a history of injection phobia Patients with scalp infection or inflammation Patients with serious and uncontrolled internal diseases such as diabetes and autoimmune diseases Patients with unrealistic expectations of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased rate of hair growth. Timepoint: A visit is done 3 months and 6 months after drug treatment. Method of measurement: Dermoscopic trichoscopy and hair count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Keshtkar
Shiraz University of Medical Sciences
Outcome results
None listed